{"ticker": {"uuid": "d4b45d20-268b-4fce-9648-711a89e5df48", "symbol": "AVLN", "name": "Avalyn Pharma Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Price to sales forward of Avalyn Pharma Inc. \u2013 NASDAQ:AVLN", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPd2xYVGxBWWFKRjJHdzBWeUJSUU5LQTdvS29qazNkODNBSVdta2JKZDBnVEhkYWloaHRNWFhlTXhSQjFaTURBRzMybDlxZ2Zfbm9YMmpYTHNkYzBKWW5QMXNpY2pYb2JrSEpjSmRySm54elVPY0hKSzFaaWNMeEZCT1lsWTVKVGFkbnNzODktdF9sMFpBWWdpZHN6RGJuZw?oc=5", "source_name": "TradingView", "published_at": "2026-07-20T20:05:23+00:00", "published_display": "20 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Inc (AVLN:UW): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE93djRWV1VtcFhnYjJkbGloQUs3b3BrelJ3eXFQNXhGNW5yZ2xNNGJWUDFtWE80SUV5b1N5b2tuRTUxd25kQVpsaDZIUDUzaUxiX1NJcA?oc=5", "source_name": "BNN Bloomberg", "published_at": "2026-07-20T03:54:52+00:00", "published_display": "20 Jul 2026 03:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Inc. (NASDAQ:AVLN) Receives Average Rating of \"Buy\" from Analysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQYmdxYUtIaWhNeFdMQU81eWxKYjY0YlU5RTN0TENWa2g1QVRYYjZNT3EwTnI2M1ZTdldpRUY2dTUtbEtkb3l1RXVZaF9VbEZOQkdZR1AzZU9CUG5oRzFjbmtValNVYWxFc3ZVR3EwaUtkb0hxekdsVXlWNHh6czlPbFpGN0NzVlBYSHViZ2w3TzV6V3RTd3U3dDJpZ0hWN0dGZWpUSlJCWWtGbVkweEZhaGhrbHlfZWxNM1AzSFRWVTZRR1ByYWc?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-18T10:18:06+00:00", "published_display": "18 Jul 2026 10:18", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma (NASDAQ:AVLN) Shares Up 5.3% - Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNWVN1LXc1VEhoN1lMVHpNTC14NnJ5amZiZ3NNNEUwQm1tcDFuNnZMUW5uV1lOVlYyUE1NQVBWZlVfTV9MV0RWTUF0WWRZT0ROelMwMnczQnEtdjlCc2xPMkdmUFY5cks4Y0ZtUFdfRThJQkdiYjJMSHFxRm9DcnJGby1tMTB3NllfWlFJeGktMnFRT1dqSHFNTUNGdldoeXNFSG9V?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-17T17:00:02+00:00", "published_display": "17 Jul 2026 17:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Avalyn Pharma Inc. - common stock (AVLN) Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE1ZeXFzUUJITDFnMk1rSVRjT2VpS2JsUVVDLV9oMy1xdXVLNmV4UnAtd0RwdUMwYUFvUXhmN1NvVVBTSkRZR1JsVXNNQkJCSkozMmFLZXNFMUY3dw?oc=5", "source_name": "FinancialContent", "published_at": "2026-07-16T16:32:00+00:00", "published_display": "16 Jul 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVALYN PHARMA INC (AVLN) News Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxNZ1dRM0gwRmdMMTk5U0NoU2k1RGlrWWplb3VZa2dqNERZdVIyUWNkU0psU3d5VWJueC1TYUpMWHFReGFrN2RrTGdHaXVqY2hIRXZQM2VmcGhaenFNVXItcFZCV1VZYlNMaWxFMms1UEtnNUZvQWwwN2Y2WEhQVjVBVmVLSnQxUDJGVWhHUmU2VDlNSUVra0g0cnNqdURCWTZVWVQ3ZVNEU1dUMWJ0N0NzVXRLYUxGeGNFQVNiRjdDOUtMOVFwaEJQdVZmMEloSC0xeTlFclVoSDZTdWdJR2VhcE9Id01oTUNkV3RnUVdjZzBNWmtIMVV6TDg2bGlLYUFwdWM4WEFhWFRNbXJnVTlNRDZTa0M5YXI5dkczUy1TblhrSGFtNW41WWdNY0RvbnNFU0E?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T16:16:22+00:00", "published_display": "13 Jul 2026 16:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What It Means To Hold Moderna Stock In A Crash", "summary": "", "url": "https://finance.yahoo.com/m/a3ba3972-13e7-3e73-b9a5-87c0993db364/what-it-means-to-hold-moderna.html", "source_name": "Trefis", "published_at": "2026-07-13T13:12:08+00:00", "published_display": "13 Jul 2026 13:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Avalyn Pharma (AVLN) Short Interest & Short Float | Updated Jul 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE9DRTVpcS12alFZZ1JrRnNCaXROUXhXeUMzcWZkUVFDS1BOcWZKS1ZwcjU3ZFN2WVkteVpyUnl6aDk5OTVNU1A3clZ6cy1EUnotamNsQ3hqSTBZd1NSa2lvZUlubEZUbk1iZldXTTdR?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/avalyn-completes-target-enrollment-phase-120000324.html", "source_name": "GlobeNewswire", "published_at": "2026-06-17T12:00:00+00:00", "published_display": "17 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead", "summary": "", "url": "https://finance.yahoo.com/m/c3be1d4c-835a-3727-a0b4-130334cbca8a/avalyn-pharma-outlines.html", "source_name": "MarketBeat", "published_at": "2026-06-06T02:06:10+00:00", "published_display": "06 Jun 2026 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/avalyn-q1-earnings-snapshot-120755335.html", "source_name": "Associated Press", "published_at": "2026-06-03T12:07:55+00:00", "published_display": "03 Jun 2026 12:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/avalyn-reports-first-quarter-2026-110000823.html", "source_name": "GlobeNewswire", "published_at": "2026-06-03T11:00:00+00:00", "published_display": "03 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Avalyn Pharma (AVLN) Valuation As Investors React To Recent Share Price Moves", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQaWxsMHVqaWFXVXh4QWlFeW1hNElIZXU5U1J0RElPeXVSNTdrNUtrdXRHcWZhYjBhQlIzOVdsNHdpRnJwVy1sMTRQX1ZVYlRhR3BkOWFaQjNGN1NkVEZJWmt5NHlXQ2llbXl4VEl3UDI1OVIxNkZvUy1IemlBLVdYMjE3aEM4enVvT3VKWE1qejhVOGE4ckJqUFlZR29CbEl4SURSck53?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn to Participate in the Jefferies Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/news/avalyn-participate-jefferies-global-healthcare-120000568.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T12:00:00+00:00", "published_display": "27 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "--Guggenheim Initiates Avalyn Pharma at Buy With $80 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/guggenheim-initiates-avalyn-pharma-buy-111518460.html", "source_name": "MT Newswires", "published_at": "2026-05-26T11:15:18+00:00", "published_display": "26 May 2026 11:15", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies Initiates Avalyn Pharma at Buy With $52 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/jefferies-initiates-avalyn-pharma-buy-111448130.html", "source_name": "MT Newswires", "published_at": "2026-05-26T11:14:48+00:00", "published_display": "26 May 2026 11:14", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley initiates Avalyn Pharma stock coverage with overweight rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOTEhSNDdYWi1JU1BSMUpXV0NOYzdvWFFQVkwyY1ZkaG41UXJSc3NBek90VFE5UDhpaWsyRjMyOTBLdHAtUGVGdlJvWktPek9lZnZncmJjUmUwQW1pWm1TclhwZlROMHFNLTRaNXJiWUVLYU9VMkx1Y1c3WHB0WklhdmRRTnhsTFRWWUxPS3RWbXVFSmpUSGZOUkZWZktxVVJWOEtCUTkwS3JtM2pVc0lGS0dabE9NSGZVckRXYlBDd0ZjRmZleTBVWVoxQUxuYnRjMXc?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/avalyn-announces-additional-long-term-120000578.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T12:00:00+00:00", "published_display": "21 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma (AVLN) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE8yMVUxY3p6NURqNDFDNDJhN0RFcC1vRTJvQ3F2M3hkODdlMHRzMEdnSndmMnRlY2ZubmpYS0xTWmRXQmVQWldveFlCNWYwSHg4SmhKLW9pU1hXLXRQRHJyUXlydEZMUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-16T17:57:59+00:00", "published_display": "16 May 2026 17:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Avalyn Pharma (AVLN) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTFBKdldZX2NQUVc4cTJ0Q21Ja1VnQzRERGxHR3kwbXV1c2VCZktvbWFFeTFEdnJNSTJwVkNzTEozU3l4NXd2c2ZHbWpFUUhxclVnNUhndFpCSkRJeU1yeTNGc2VmNXRablRUNHE5bEt5bkxSc0FHbmc?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-02T02:41:21+00:00", "published_display": "02 May 2026 02:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma (AVLN) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9wU3dyY0NBLXJBTmZkMnZFS3ZjOWRpd3MyM1FVOTBuSzhwUDE2ZEU5d2RrdTc3eEE0a1FfRURMT0dGWUxpOWtiemRYSzVQSUhKTTE3UU5KNWdFQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-02T02:41:20+00:00", "published_display": "02 May 2026 02:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Inc. (AVLN) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFA0cW1FV2NfejlDTnVmVkl1eUVLUVNnOGhXa3p1ZWNvX1JYTkJsS2ZSQUxSTTRYd0JNdkllN1NEZ0pJSjhRbG1UNS1wbnJ4dw?oc=5", "source_name": "StocksToTrade", "published_at": "2026-05-01T08:01:56+00:00", "published_display": "01 May 2026 08:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma closes $345 million IPO on Nasdaq", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQdW4ybDN3bS1FMl9ONTdHSVdQVEk2ZVdqQ3UteURub0wxd2V6QTNLTU80N2ZoYmtRZGtBc2NUNTQtS0hxcERSOFV3SnFUUWFGaXdZVVU0RHFfWkk3SzNqWVNwdFBVVmllRGNXOXRQNFNlZUZJOE83SFhYZDhtRnVFRTJhOHo4U2Y1NzF6Zi1zdjBGTHlsUnJvWS1Yekw1QjRmNmtkNDRR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters\u2019 Option to Purchase Additional Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNaEVTbGxiUDJlUWRzc1VQRW12X2l6SG9pQW1tMHozcGNDTW1TdzlSSkhQd2FSTVJ0ZURtVTlremhtdVFHYmpMVnV2RXpWa0duT0hNTkdoRjY4dnQ2VTVKb2dVS0V4dUNtWkxjSE9McmF0QXBjLXNCNHNkMEl5X2s3TGpsQTViSG0tX2QzOWZWOGhrWEdPUHF1Y1lnWEE1b1FnZFpzUndxaw?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pulmonary drug developer Avalyn surges on IPO (AVLN:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPLVR0NDBZXzZ5Tnloc3VXOEs0dFRibFQwRHByNDkxNldlLVZOVkQ4ZHlCaUJ3VFU4OUI0ZnhZSjQ2TEowS1FfdkJSSS1VUVhLN1NmQ3cxMDd3NzBqdG5IbGRobjJTdjc1ekV5UGtLeDJ4a0FXVHFZeWxpVWE5MzlBREp5aVg3RzFTYkxv?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Avalyn Pharma (NASDAQ:AVLN) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNVkFuYlJMLVNBcHc2bXAwaG4tcVcwdGxyVTVZNnJqRTR2VGtVTHNzdS04OXZOTHNrZzhmSy1zY3ZfeGRKaTBpWWdYd0FUeFdzUmd0a3U0ZXFKXzFBczRxX1dOUGN6RHdFSmNrV0gzVnhLSGlKaUpXMkNtRFlCUy1nSmFKQ3BtQ2h1VWplR3VVT2R4VHpxb3J4a2pGWQ?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPSS1JdGVnT21pTEZRVjhudEJ3am82Wk9oWTR5el9Ya3l0cnV1ZHVEMjgtMFhfOUZBbkI3TllvQnVpSFVCZUM3ZlRXUGxUWDlPNmRCY1hNLXpXcmZwUjJzTFlHNTI5OEhIbjFqaFFMb1R1OWZfbFZLNWJza0VXWjRyXy12SjRPbkdFODZUcVFLVGloRC1rdTdBYWJ1dnEycjhreDVJZDBfVFk?oc=5", "source_name": "MedCity News", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPVzRWVlhtVm1ZUTd6eGhUeW1EWm9DWW1wUk9rMFZicWl3dnFaR1RMcG5HaEREaHVCTlliNXlaeFFhWmNuMEdfU29oSWpWQzBlYWlwZWZZQlJTLWcxMkJLMjh6SEJrRHVtTHBOZG5YSTN2V19hM3J6OW1CT1FXUDJDSV95Q2ZVVW9uRWtoamlfcGxUcnlKOUMtRXJwU193aHZpMXRDaDBqRHZVWVQzVkt1VHdn?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFB5NXJBZWs2UW9nQmlONTA3NWtQeFVXdm1VcDYyRlJSbE1BSzNYQkpfV09JRURlN1hydDJicGVQbm5lXzJoZWcycTZldTY3czlM?oc=5", "source_name": "CNN", "published_at": "2026-04-25T19:18:18+00:00", "published_display": "25 Apr 2026 19:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "AVLN Stock Price and Chart \u2014 NASDAQ:AVLN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE4ybkxNcVAyQmpWWkhySlFETkZMazB6enFiWm54V0VnU2YwaDhFZ2ZZMkpVNGZDTkhXcHpQbFdrS3RxLXUzZk11T3U2clZUdWpXclBucXRmTVh5ME9N?oc=5", "source_name": "TradingView", "published_at": "2026-04-12T09:28:16+00:00", "published_display": "12 Apr 2026 09:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "AVALYN PHARMACEUTICALS (AVLN) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFAzNmRGZWZoTXp4Y0ZnMjFFMDdGNjZaZ0E0Q1NxVm0tMGVPUmQ3ZTFQeXJFeG84ZEZPSXNWZ3d6ZFZIenR1MkhCbmltdUFzam1ZWkY4?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-25T21:51:59+00:00", "published_display": "25 Mar 2026 21:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HROW Stock Price and Chart \u2014 NASDAQ:HROW", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBiZGJDTzNtLTV4eF81QXN5d2NRWmNKYk5yaHYyalltNVctX3drOVBuLWwzOE1VRXQ1LUtLQUZDaXlJTXJiWG5yUV9QYVI3bGtIQ0xwc2NyY05QZGpB?oc=5", "source_name": "TradingView", "published_at": "2019-01-04T19:43:24+00:00", "published_display": "04 Jan 2019 19:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to sales forward of Avalyn Pharma Inc. \u2013 NASDAQ:AVLN", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPd2xYVGxBWWFKRjJHdzBWeUJSUU5LQTdvS29qazNkODNBSVdta2JKZDBnVEhkYWloaHRNWFhlTXhSQjFaTURBRzMybDlxZ2Zfbm9YMmpYTHNkYzBKWW5QMXNpY2pYb2JrSEpjSmRySm54elVPY0hKSzFaaWNMeEZCT1lsWTVKVGFkbnNzODktdF9sMFpBWWdpZHN6RGJuZw?oc=5", "source_name": "TradingView", "published_at": "2026-07-20T20:05:23+00:00", "published_display": "20 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Inc (AVLN:UW): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE93djRWV1VtcFhnYjJkbGloQUs3b3BrelJ3eXFQNXhGNW5yZ2xNNGJWUDFtWE80SUV5b1N5b2tuRTUxd25kQVpsaDZIUDUzaUxiX1NJcA?oc=5", "source_name": "BNN Bloomberg", "published_at": "2026-07-20T03:54:52+00:00", "published_display": "20 Jul 2026 03:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Inc. (NASDAQ:AVLN) Receives Average Rating of \"Buy\" from Analysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQYmdxYUtIaWhNeFdMQU81eWxKYjY0YlU5RTN0TENWa2g1QVRYYjZNT3EwTnI2M1ZTdldpRUY2dTUtbEtkb3l1RXVZaF9VbEZOQkdZR1AzZU9CUG5oRzFjbmtValNVYWxFc3ZVR3EwaUtkb0hxekdsVXlWNHh6czlPbFpGN0NzVlBYSHViZ2w3TzV6V3RTd3U3dDJpZ0hWN0dGZWpUSlJCWWtGbVkweEZhaGhrbHlfZWxNM1AzSFRWVTZRR1ByYWc?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-18T10:18:06+00:00", "published_display": "18 Jul 2026 10:18", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma (NASDAQ:AVLN) Shares Up 5.3% - Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNWVN1LXc1VEhoN1lMVHpNTC14NnJ5amZiZ3NNNEUwQm1tcDFuNnZMUW5uV1lOVlYyUE1NQVBWZlVfTV9MV0RWTUF0WWRZT0ROelMwMnczQnEtdjlCc2xPMkdmUFY5cks4Y0ZtUFdfRThJQkdiYjJMSHFxRm9DcnJGby1tMTB3NllfWlFJeGktMnFRT1dqSHFNTUNGdldoeXNFSG9V?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-17T17:00:02+00:00", "published_display": "17 Jul 2026 17:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Inc. - common stock (AVLN) Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE1ZeXFzUUJITDFnMk1rSVRjT2VpS2JsUVVDLV9oMy1xdXVLNmV4UnAtd0RwdUMwYUFvUXhmN1NvVVBTSkRZR1JsVXNNQkJCSkozMmFLZXNFMUY3dw?oc=5", "source_name": "FinancialContent", "published_at": "2026-07-16T16:32:00+00:00", "published_display": "16 Jul 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVALYN PHARMA INC (AVLN) News Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxNZ1dRM0gwRmdMMTk5U0NoU2k1RGlrWWplb3VZa2dqNERZdVIyUWNkU0psU3d5VWJueC1TYUpMWHFReGFrN2RrTGdHaXVqY2hIRXZQM2VmcGhaenFNVXItcFZCV1VZYlNMaWxFMms1UEtnNUZvQWwwN2Y2WEhQVjVBVmVLSnQxUDJGVWhHUmU2VDlNSUVra0g0cnNqdURCWTZVWVQ3ZVNEU1dUMWJ0N0NzVXRLYUxGeGNFQVNiRjdDOUtMOVFwaEJQdVZmMEloSC0xeTlFclVoSDZTdWdJR2VhcE9Id01oTUNkV3RnUVdjZzBNWmtIMVV6TDg2bGlLYUFwdWM4WEFhWFRNbXJnVTlNRDZTa0M5YXI5dkczUy1TblhrSGFtNW41WWdNY0RvbnNFU0E?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T16:16:22+00:00", "published_display": "13 Jul 2026 16:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What It Means To Hold Moderna Stock In A Crash", "summary": "", "url": "https://finance.yahoo.com/m/a3ba3972-13e7-3e73-b9a5-87c0993db364/what-it-means-to-hold-moderna.html", "source_name": "Trefis", "published_at": "2026-07-13T13:12:08+00:00", "published_display": "13 Jul 2026 13:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma (AVLN) Short Interest & Short Float | Updated Jul 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE9DRTVpcS12alFZZ1JrRnNCaXROUXhXeUMzcWZkUVFDS1BOcWZKS1ZwcjU3ZFN2WVkteVpyUnl6aDk5OTVNU1A3clZ6cy1EUnotamNsQ3hqSTBZd1NSa2lvZUlubEZUbk1iZldXTTdR?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/avalyn-completes-target-enrollment-phase-120000324.html", "source_name": "GlobeNewswire", "published_at": "2026-06-17T12:00:00+00:00", "published_display": "17 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead", "summary": "", "url": "https://finance.yahoo.com/m/c3be1d4c-835a-3727-a0b4-130334cbca8a/avalyn-pharma-outlines.html", "source_name": "MarketBeat", "published_at": "2026-06-06T02:06:10+00:00", "published_display": "06 Jun 2026 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/avalyn-q1-earnings-snapshot-120755335.html", "source_name": "Associated Press", "published_at": "2026-06-03T12:07:55+00:00", "published_display": "03 Jun 2026 12:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/avalyn-reports-first-quarter-2026-110000823.html", "source_name": "GlobeNewswire", "published_at": "2026-06-03T11:00:00+00:00", "published_display": "03 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Avalyn Pharma (AVLN) Valuation As Investors React To Recent Share Price Moves", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQaWxsMHVqaWFXVXh4QWlFeW1hNElIZXU5U1J0RElPeXVSNTdrNUtrdXRHcWZhYjBhQlIzOVdsNHdpRnJwVy1sMTRQX1ZVYlRhR3BkOWFaQjNGN1NkVEZJWmt5NHlXQ2llbXl4VEl3UDI1OVIxNkZvUy1IemlBLVdYMjE3aEM4enVvT3VKWE1qejhVOGE4ckJqUFlZR29CbEl4SURSck53?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn to Participate in the Jefferies Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/news/avalyn-participate-jefferies-global-healthcare-120000568.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T12:00:00+00:00", "published_display": "27 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "--Guggenheim Initiates Avalyn Pharma at Buy With $80 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/guggenheim-initiates-avalyn-pharma-buy-111518460.html", "source_name": "MT Newswires", "published_at": "2026-05-26T11:15:18+00:00", "published_display": "26 May 2026 11:15", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies Initiates Avalyn Pharma at Buy With $52 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/jefferies-initiates-avalyn-pharma-buy-111448130.html", "source_name": "MT Newswires", "published_at": "2026-05-26T11:14:48+00:00", "published_display": "26 May 2026 11:14", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley initiates Avalyn Pharma stock coverage with overweight rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOTEhSNDdYWi1JU1BSMUpXV0NOYzdvWFFQVkwyY1ZkaG41UXJSc3NBek90VFE5UDhpaWsyRjMyOTBLdHAtUGVGdlJvWktPek9lZnZncmJjUmUwQW1pWm1TclhwZlROMHFNLTRaNXJiWUVLYU9VMkx1Y1c3WHB0WklhdmRRTnhsTFRWWUxPS3RWbXVFSmpUSGZOUkZWZktxVVJWOEtCUTkwS3JtM2pVc0lGS0dabE9NSGZVckRXYlBDd0ZjRmZleTBVWVoxQUxuYnRjMXc?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/avalyn-announces-additional-long-term-120000578.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T12:00:00+00:00", "published_display": "21 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma (AVLN) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE8yMVUxY3p6NURqNDFDNDJhN0RFcC1vRTJvQ3F2M3hkODdlMHRzMEdnSndmMnRlY2ZubmpYS0xTWmRXQmVQWldveFlCNWYwSHg4SmhKLW9pU1hXLXRQRHJyUXlydEZMUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-16T17:57:59+00:00", "published_display": "16 May 2026 17:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma (AVLN) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTFBKdldZX2NQUVc4cTJ0Q21Ja1VnQzRERGxHR3kwbXV1c2VCZktvbWFFeTFEdnJNSTJwVkNzTEozU3l4NXd2c2ZHbWpFUUhxclVnNUhndFpCSkRJeU1yeTNGc2VmNXRablRUNHE5bEt5bkxSc0FHbmc?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-02T02:41:21+00:00", "published_display": "02 May 2026 02:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma (AVLN) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9wU3dyY0NBLXJBTmZkMnZFS3ZjOWRpd3MyM1FVOTBuSzhwUDE2ZEU5d2RrdTc3eEE0a1FfRURMT0dGWUxpOWtiemRYSzVQSUhKTTE3UU5KNWdFQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-02T02:41:20+00:00", "published_display": "02 May 2026 02:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Inc. (AVLN) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFA0cW1FV2NfejlDTnVmVkl1eUVLUVNnOGhXa3p1ZWNvX1JYTkJsS2ZSQUxSTTRYd0JNdkllN1NEZ0pJSjhRbG1UNS1wbnJ4dw?oc=5", "source_name": "StocksToTrade", "published_at": "2026-05-01T08:01:56+00:00", "published_display": "01 May 2026 08:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma closes $345 million IPO on Nasdaq", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQdW4ybDN3bS1FMl9ONTdHSVdQVEk2ZVdqQ3UteURub0wxd2V6QTNLTU80N2ZoYmtRZGtBc2NUNTQtS0hxcERSOFV3SnFUUWFGaXdZVVU0RHFfWkk3SzNqWVNwdFBVVmllRGNXOXRQNFNlZUZJOE83SFhYZDhtRnVFRTJhOHo4U2Y1NzF6Zi1zdjBGTHlsUnJvWS1Yekw1QjRmNmtkNDRR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters\u2019 Option to Purchase Additional Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNaEVTbGxiUDJlUWRzc1VQRW12X2l6SG9pQW1tMHozcGNDTW1TdzlSSkhQd2FSTVJ0ZURtVTlremhtdVFHYmpMVnV2RXpWa0duT0hNTkdoRjY4dnQ2VTVKb2dVS0V4dUNtWkxjSE9McmF0QXBjLXNCNHNkMEl5X2s3TGpsQTViSG0tX2QzOWZWOGhrWEdPUHF1Y1lnWEE1b1FnZFpzUndxaw?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pulmonary drug developer Avalyn surges on IPO (AVLN:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPLVR0NDBZXzZ5Tnloc3VXOEs0dFRibFQwRHByNDkxNldlLVZOVkQ4ZHlCaUJ3VFU4OUI0ZnhZSjQ2TEowS1FfdkJSSS1VUVhLN1NmQ3cxMDd3NzBqdG5IbGRobjJTdjc1ekV5UGtLeDJ4a0FXVHFZeWxpVWE5MzlBREp5aVg3RzFTYkxv?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Avalyn Pharma (NASDAQ:AVLN) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNVkFuYlJMLVNBcHc2bXAwaG4tcVcwdGxyVTVZNnJqRTR2VGtVTHNzdS04OXZOTHNrZzhmSy1zY3ZfeGRKaTBpWWdYd0FUeFdzUmd0a3U0ZXFKXzFBczRxX1dOUGN6RHdFSmNrV0gzVnhLSGlKaUpXMkNtRFlCUy1nSmFKQ3BtQ2h1VWplR3VVT2R4VHpxb3J4a2pGWQ?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPSS1JdGVnT21pTEZRVjhudEJ3am82Wk9oWTR5el9Ya3l0cnV1ZHVEMjgtMFhfOUZBbkI3TllvQnVpSFVCZUM3ZlRXUGxUWDlPNmRCY1hNLXpXcmZwUjJzTFlHNTI5OEhIbjFqaFFMb1R1OWZfbFZLNWJza0VXWjRyXy12SjRPbkdFODZUcVFLVGloRC1rdTdBYWJ1dnEycjhreDVJZDBfVFk?oc=5", "source_name": "MedCity News", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPVzRWVlhtVm1ZUTd6eGhUeW1EWm9DWW1wUk9rMFZicWl3dnFaR1RMcG5HaEREaHVCTlliNXlaeFFhWmNuMEdfU29oSWpWQzBlYWlwZWZZQlJTLWcxMkJLMjh6SEJrRHVtTHBOZG5YSTN2V19hM3J6OW1CT1FXUDJDSV95Q2ZVVW9uRWtoamlfcGxUcnlKOUMtRXJwU193aHZpMXRDaDBqRHZVWVQzVkt1VHdn?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFB5NXJBZWs2UW9nQmlONTA3NWtQeFVXdm1VcDYyRlJSbE1BSzNYQkpfV09JRURlN1hydDJicGVQbm5lXzJoZWcycTZldTY3czlM?oc=5", "source_name": "CNN", "published_at": "2026-04-25T19:18:18+00:00", "published_display": "25 Apr 2026 19:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVLN Stock Price and Chart \u2014 NASDAQ:AVLN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE4ybkxNcVAyQmpWWkhySlFETkZMazB6enFiWm54V0VnU2YwaDhFZ2ZZMkpVNGZDTkhXcHpQbFdrS3RxLXUzZk11T3U2clZUdWpXclBucXRmTVh5ME9N?oc=5", "source_name": "TradingView", "published_at": "2026-04-12T09:28:16+00:00", "published_display": "12 Apr 2026 09:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVALYN PHARMACEUTICALS (AVLN) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFAzNmRGZWZoTXp4Y0ZnMjFFMDdGNjZaZ0E0Q1NxVm0tMGVPUmQ3ZTFQeXJFeG84ZEZPSXNWZ3d6ZFZIenR1MkhCbmltdUFzam1ZWkY4?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-25T21:51:59+00:00", "published_display": "25 Mar 2026 21:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cava Stock Surges 24% After Upbeat Earnings and Strong 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQcV9JR0t0QUpQRWhQU0JxOGZld2wxZmNTb0ZoV05TZVBhUjRxRGF2Zno5YWRaVkxKRzNsbk8yY01fdk95S09xcV9aT0FFS1A3Zzhfd0ZLVVVRVU1jY1BiZmZ6T0drMjlfLVNXMTVBZjdtWXdNTEdHTEc2ejFqX1lTREs3eXBhbWRjaUhRWHJMZlYxWGFGZnYwOUJ2Mm9uQQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HROW Stock Price and Chart \u2014 NASDAQ:HROW", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBiZGJDTzNtLTV4eF81QXN5d2NRWmNKYk5yaHYyalltNVctX3drOVBuLWwzOE1VRXQ1LUtLQUZDaXlJTXJiWG5yUV9QYVI3bGtIQ0xwc2NyY05QZGpB?oc=5", "source_name": "TradingView", "published_at": "2019-01-04T19:43:24+00:00", "published_display": "04 Jan 2019 19:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 74, "total_relevant": 55, "sentiment_summary": {"positive": 14, "negative": 2, "neutral": 39, "score": 54, "total": 55, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 17.55, "count": 30}, {"event": "earnings", "label": "Earnings", "weight": 8.95, "count": 17}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 14, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 28.3, "latest_week": "2026-07-17", "one_week_move": 0.9, "four_week_move": -10.0, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -3.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 31.4741, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.9% over one week, -10.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 53, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "MarketBeat", "count": 7}, {"label": "TradingView", "count": 5}, {"label": "GlobeNewswire", "count": 4}, {"label": "MT Newswires", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "TIKR.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 47}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 30}, {"label": "Earnings", "count": 17}, {"label": "Analyst action", "count": 5}, {"label": "Guidance", "count": 2}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "47", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.9% over one week, -10.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to sales forward of Avalyn Pharma Inc. \u2013 NASDAQ:AVLN"}], "updated_at": "2026-07-22T08:40:47.853969+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}